Sales for infant formulas have increased substantially in global markets. Additionally, an aging population and increased awareness of the relationship between health and nutrition is driving sales for formulas in most regions worldwide. Newly updated with base year data for 2014, Clinical Nutrition Products: A Worldwide Perspective is a Kalorama Information report that focuses on three primary segments of essential medical nutrition:
Infant Nutrition (Milk-based, Soy-based, Elemental, Follow-Up, Organic, Probiotic / Prebiotic, Premature, Newborn and Other Specialized Formulas)
Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients)
Parenteral Nutrition (indicated for a variety of disorders including Gastrointestinal Disease, Burns, Extensive Wounds, Cancer, AIDS)
Information is presented as a worldwide overview, with special emphasis on the U.S., Europe, Asia Pacific and other key markets. The market segments provide an overview, description of products on the market, recent business activities, market estimates and forecasts, and competitive analysis of leading providers. Revenues for each segment were generated using dollar and unit sales for each product. The report includes incidence of conditions that often require enteral or parenteral feeding, birth rates, over 65 population, and overall global population.
Coverage of Issues and Trends in Clinical Nutrition
Many of the issues impacting the clinical nutrition market focus on safety concerns. These have been at the forefront over the past decade with respect to infant formulas and end-of-life complications. The issues and trends that are currently impacting the clinical nutrition market include:
Wound Care Applications
Parenteral nutrition shortages
Consolidation in China
Breast milk debate
Reimbursement of nutrition products
Changing landscape of elderly care
Nutrition and education
DHA and ARA additives
Recalled infant formulas
Acquisition, mergers and alliances
Enteral feeding pump suppliers and products
A Growing Market with Thriving Competition
A handful of companies, ranging from global nutritional manufacturers to leading pharmaceutical companies, dominate competition in the clinical nutrition market. The majority of competitive participation takes place in developed regions such as the United States, Western Europe, and Japan. Many companies, however, are expanding into less developed regions, intensifying competition in less-tapped markets. China, for example, is among the expanding competitive regions where companies continue to break into the growing demand for clinical nutrition in new world markets. Companies highlighted in this study include:
For the purpose of this study, Kalorama Information conducted interviews with more than 40 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to the revenue and market share data presented in this report. Specific interviews with nutrition company representatives included marketing directors, division managers, and product representatives.
The base year for data is 2014. Historical data is provided for the years 2007 through 2013, with forecast data provided for 2015 through 2021. Compound annual growth rates (CAGRs) are provided for the 2007-2014, 2014-2021 and 2007-2021 periods for each industry segment covered. Competitive analysis is provided for the year 2014. The forecasted market analysis for 2015-2021 was based on demographic trends, new developments, and global expansion. All market data pertains to the world market at the manufacturers’ level.
Search inside this report
Departmental Site License (one location, 10 users)